Joslin's volunteer Board of Trustees works closely with Joslin's executive staff to assure our organization is both grounded on a steady foundation and has the freedom to create new knowledge — the hallmark of this one-of-a-kind center.

Ann Lagasse, Chair

Board Chair
Principal, Ocean Havens LLC

Todd Abbrecht

Head of Private Equity, Thomas H. Lee Partners

Susan Dacey

CEO and Chair of the Board of Directors, Industrial Polymers and Chemicals, Inc.

Michael K. Devlin

Executive Vice President and Chief Financial Officer, Randolph Bancorp, Inc.

Jessica Hopfield, PhD

Healthcare Strategist and Biotech Investor
Former Director at McKinsey and Company

Ralph James

Executive Director or External Relations Harvard Business School

Martin Pasqualini

Managing Director and Founding Member of CCA Group LLC

James Peterson

Former CEO, Haemonetics Corporation

Geoffrey Rehnert

Co-CEO and Co-Founder, Audax Group

Arthur H. Rubenstein, MBBCh

Dean Emeritus Perelman School of Medicine at University of Pennsylvania

Mark E. Russell

Vice President of Engineering, Technology, and Mission Assurance, Raytheon

Stefany Shaheen

President & Co-Founder, Good Measures, LLC

Ex Officio

Roberta Herman, MD

President and CEO, Joslin Diabetes Center

Sanjeev Mehta, MD, MPH

Interim Chief Medical Officer and Senior Vice President, Joslin Diabetes Center

George King, MD

Director of Research, Senior Vice President and Head of Section on Vascular Cell Biology, Joslin Diabetes Center

Honorary Trustees

Ken Quickel, MD

President Emeritus, Joslin Diabetes Center